BioCentury
ARTICLE | Company News

GeneMax, University of British Columbia deal

February 23, 2004 8:00 AM UTC

GMXX's GeneMax Pharmaceuticals Inc. subsidiary (Vancouver, B.C.) received an exclusive worldwide license from the university to an assay that screens compounds that regulate immune responses. ...